Mahaney Paige (CIK 2040313) reported 6 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-02-18). Recent activity: Buy CCCC (240,000 shares), Buy CCCC (7,050 shares), Sell CCCC (2,446 shares), Buy CCCC (19,200 shares), Sell CCCC (5,644 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-02-18 | C4 Therapeutics, Inc. (CCCC) | Chief Scientific Officer | Buy | 240,000 | $0 |
| 2026-02-18 | C4 Therapeutics, Inc. (CCCC) | Chief Scientific Officer | Buy | 7,050 | $0 |
| 2026-02-18 | C4 Therapeutics, Inc. (CCCC) | Chief Scientific Officer | Sell | 2,446 | $4,623 |
| 2025-10-30 | C4 Therapeutics, Inc. (CCCC) | Chief Scientific Officer | Buy | 19,200 | $0 |
| 2025-10-30 | C4 Therapeutics, Inc. (CCCC) | Chief Scientific Officer | Sell | 5,644 | $14,562 |
| 2025-02-18 | C4 Therapeutics, Inc. (CCCC) | Chief Scientific Officer | Buy | 28,200 | $0 |
Source: SEC Form 4 filings · as of 2026-02-18